Jorge Rojas-Rivera

The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

Gema Fernández‐Juárez, Jorge Rojas-Rivera, Anne-Els van de Logt et al. · Kidney International · 2020 · 220 citations · Full text

Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria

Eduardo Gutiérrez, I. Zamora, José Ballarín et al. · Journal of the American Society of Nephrology · 2012 · 175 citations · Full text

Glomerular Disease, Renal Pathology, Immunology +22

Effectiveness of mycophenolate mofetil in C3 glomerulonephritis

Cristina Rabasco, Teresa Cavero, Elena Román et al. · Kidney International · 2015 · 165 citations

Glomerulonephritis, Mycophenolate Mofetil, Renal Function +7

Eculizumab in secondary atypical haemolytic uraemic syndrome

Teresa Cavero, Cristina Rabasco, Antía López et al. · Nephrology Dialysis Transplantation · 2016 · 160 citations · Full text

Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus

J. Caro, E. Gutiérrez-Solís, Jorge Rojas-Rivera et al. · Nephrology Dialysis Transplantation · 2014 · 64 citations · Full text